Rosai Dorfman Hastalığı

Miȩkus A, Stefanowicz J, Kobierska-Gulida G, et al. Rosai-Dorfman disease as a rare cause of cervical lymphadenopathy – case report and literature review. Cent Eur J Immunol. 2018;43(3):341. doi: 10.5114/ceji.2018.80055

Foucar E, Rosai J, Dorfman R. Sinus histiocytosis with massive lymphadenopathy (Rosai-Dorfman disease): review of the entity. Semin Diagn Pathol. 1990;7(1):19-73.

Natkunam Y, Rossi S, Demicco EG, et al. Rosai-Dorfman Disease. Chan J (ed), In: WHO Classification of Tumours Editorial Board. Haematolymphoid tumours. 5th ed. Lyon (France): International Agency for Research on Cancer; 2024.

Rosai J, Dorfman RF. Sinus Histiocytosis with massive lymphadenopathy: a pseudolympomatous benign disorder.Analysis of 34 cases. Cancer. 1972;30(5):1174-88.

Rosai J, Dorfman RF. Sinus Histiocytosis with massive lymphadenopathy. A newly recognized benign clinicopathological entity. Arch Pathol. 1969;87(1):63–70.

Abla O, Jacobsen E, Picarsic J, et al. Consensus recommendations for the diagnosis and clinical management of Rosai-Dorfman-Destombes disease. Blood. 2018;131(26):2877–90. doi: 10.1182/blood-2018-03-839753.

Dalia S, Sagatys E, Sokol L, et al. Rosai-Dorfman disease: Tumor biology, clinical features, pathology, and treatment. Cancer Control. 2014;21(4):322–7.

doi: 10.1177/107327481402100408

Frater JL, Maddox JS, Obadiah JM, et al. Cutaneous Rosai-Dorfman disease: comprehensive review of cases reported in the medical literature since 1990 and presentation of an illustrative case. J Cutan Med Surg. 2006;10(6): 281-90.

doi: 10.2310/7750.2006.00067

Levine PH, Jahan N, Murari P, et al. Detection of Human Herpesvirus 6 in Tissues Involved by Sinus Histiocytosis with Massive Lymphadenopathy (Rosai-Dorfman Disease). J Infect Dis. 1992;166(2):291–5.

Mederios LJ, Miranda RN. Rosai-Dorfman Disease. Mederios LJ, Miranda RN (eds), In: Diagnostic Pathology Lymph Nodes and Extranodal Lymphomas. Third ed. Philadelphia: Elsevier; 2023.156–165.

Morgan NV, Morris MR, Cangul H, et al. Mutations in SLC29A3, encoding an equilibrative nucleoside transporter ENT3, cause a familial histiocytosis syndrome (Faisalabad histiocytosis) and familial Rosai-Dorfman disease. PLoS Genet . 2010;6(2): e1000833. doi: 10.1371/journal.pgen.1000833.

Diamond EL, Durham BH, Haroche J, et al. Diverse and Targetable Kinase Alterations Drive Histiocytic Neoplasms. Cancer Discov. 2016;6(2):154–65. doi: 10.1158/2159-8290.CD-15-0913.

Garces S, Yin CC, Patel KP, et al. Focal Rosai–Dorfman disease coexisting with lymphoma in the same anatomic site: a localized histiocytic proliferation associated with MAPK/ERK pathway activation. Modern Pathology. 2019;32(1):16–26.

doi: 10.1038/s41379-018-0152-1.

Emile JF, Abla O, Fraitag S, et al. Revised classification of histiocytoses and neoplasms of the macrophage-dendritic cell lineages. Blood. 2016;127(22):2672–81.

doi: 10.1182/blood-2016-01-690636.

Ravindran A, Goyal G, Go RS, et al. Rosai-Dorfman Disease Displays a Unique Monocyte-Macrophage Phenotype Characterized by Expression of OCT2. Am J Surg Pathol . 2021;45(1):35–44. doi: 10.1097/PAS.0000000000001617.

Baraban E, Sadigh S, Rosenbaum J, et al. Cyclin D1 expression and novel mutational findings in Rosai-Dorfman disease. Br J Haematol . 2019;186(6):837–44.

doi: 10.1111/bjh.16006.

Vujhini S, Kolte S, Satarkar R, et al. Fine needle aspiration diagnosis of Rosai-Dorfman Disease involving thyroid. J Cytol . 2012;29(1):83–5. doi: 10.4103/0970-9371.93239.

Haroche J, Abla O. Uncommon histiocytic disorders: Rosai-Dorfman, juvenile xanthogranuloma, and Erdheim-Chester disease. Hematology Am Soc Hematol Educ Program . 2015;2015(1):571–8. doi: 10.1182/asheducation-2015.1.571.

Liu L, Perry AM, Cao W, et al. Relationship between Rosai-Dorfman disease and IgG4-related disease: study of 32 cases. Am J Clin Pathol. 2013;140(3):395–402. doi:10.1309/AJCPFH0SJ6YILXJU.